Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-02-25 @ 8:58 PM
Study NCT ID:
NCT02558816
Status:
COMPLETED
Last Update Posted:
2025-07-24
First Post:
2015-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Trial of Obinutuzumab,GDC-0199 Plus Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma Patients
Sponsor:
Nantes University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-13
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-27
First Submit QC Date:
None
Study First Post Date:
2015-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-21
Last Update Post Date:
2025-07-24
Last Update Post Date Type:
ACTUAL